{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T09:29:19Z","timestamp":1751362159096,"version":"3.37.3"},"reference-count":45,"publisher":"Bentham Science Publishers Ltd.","issue":"8","funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research & Development Program of China","doi-asserted-by":"publisher","award":["2016YFC1307200"],"award-info":[{"award-number":["2016YFC1307200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009601","name":"Beijing Municipal Administration of Hospitals' Youth Program","doi-asserted-by":"publisher","award":["QML20181901"],"award-info":[{"award-number":["QML20181901"]}],"id":[{"id":"10.13039\/501100009601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81601185"],"award-info":[{"award-number":["81601185"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010876","name":"Opening Project of Shanghai Key Laboratory of Compound Chinese Medicines","doi-asserted-by":"publisher","award":["17DZ2273300"],"award-info":[{"award-number":["17DZ2273300"]}],"id":[{"id":"10.13039\/501100010876","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009601","name":"Beijing Municipal Administration of Hospitals Incubating Program","doi-asserted-by":"publisher","award":["PX2018065"],"award-info":[{"award-number":["PX2018065"]}],"id":[{"id":"10.13039\/501100009601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005081","name":"Beijing Council of Science and Technology","doi-asserted-by":"publisher","award":["Z181100004418004"],"award-info":[{"award-number":["Z181100004418004"]}],"id":[{"id":"10.13039\/501100005081","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMM"],"published-print":{"date-parts":[[2019,9,5]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Schizophrenia is a complex and debilitating mental disorder with strong heritability. Its pathogenesis involves immune dysregulation. Interleukin 15 and interleukin 15 receptor alpha(IL-15R\u03b1) are classical immune molecules. They also help maintain normal brain function, leading to our hypothesis that IL-15R\u03b1 gene(IL- 15RA) variants contribute to the pathogenesis of schizophrenia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective:<\/jats:title><jats:p>We determine whether the genetic variants of IL-15RA are associated with the development and progression of schizophrenia and whether IL-15RA single nucleotide polymorphism(SNP) plays a key role in downstream signaling transduction.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and results:<\/jats:title><jats:p>We sequenced IL-15RA exon from 132 Chinese schizophrenic patients and identified a rare variant(rs528238821) in a patient diagnosed with catatonic schizophrenia and ankylosing spondylitis(AS). We overexpressed this missense variant in cells driven by pBI-CMV vector. The cells showed attenuated STAT3 phosphorylation in response to interleukin15.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>IL-15RA mutation is rare in schizophrenic patients but interfered with IL- 15R\u03b1 intracellular signal transduction. Given the similarity of symptoms of catatonic schizophrenia and the known phenotype of IL-15R\u03b1 knockout mice, gene variation might offer diagnostic value for sub-types of schizophrenia.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1566524019666190617172054","type":"journal-article","created":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T09:35:48Z","timestamp":1561628148000},"page":"560-569","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Schizophrenia Patient Shows a Rare Interleukin 15 Receptor alpha Variant Disrupting Signal Transduction"],"prefix":"10.2174","volume":"19","author":[{"given":"Yanli","family":"Pan","sequence":"first","affiliation":[{"name":"The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, 100088, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhimin","family":"Wang","sequence":"additional","affiliation":[{"name":"The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, 100088, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangping","family":"Zhang","sequence":"additional","affiliation":[{"name":"The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, 100088, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junhua","family":"Guo","sequence":"additional","affiliation":[{"name":"The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, 100088, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuequan","family":"Zhu","sequence":"additional","affiliation":[{"name":"The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, 100088, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Zhou","sequence":"additional","affiliation":[{"name":"The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, 100088, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenrong","family":"Zhang","sequence":"additional","affiliation":[{"name":"The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, 100088, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuoli","family":"Sun","sequence":"additional","affiliation":[{"name":"The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, 100088, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Yang","sequence":"additional","affiliation":[{"name":"The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, 100088, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abba J.","family":"Kastin","sequence":"additional","affiliation":[{"name":"Pennington Biomedical Research Center, Baton Rouge, LA70808, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weihong","family":"Pan","sequence":"additional","affiliation":[{"name":"BioPotentials Consulting, Sedona, AZ 86351, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojun","family":"Wu","sequence":"additional","affiliation":[{"name":"Shanghai Key Laboratory of Compound Chinese Medicines, Institute of Chinese Material Medical, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianliang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Beijing Institute for Brain Disorders, Beijing 100069, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomin","family":"Wang","sequence":"additional","affiliation":[{"name":"Beijing Institute for Brain Disorders, Beijing 100069, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanyue","family":"Wang","sequence":"additional","affiliation":[{"name":"The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, 100088, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"He","sequence":"additional","affiliation":[{"name":"The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, 100088, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nature12818","volume":"505","author":"Stefansson H.","year":"2014","unstructured":"Stefansson H.; Meyer-Lindenberg A.; Steinberg S.; CNVs conferring risk of autism or schizophrenia affect cognition in controls. Nature 2014,505(7483),361-366","journal-title":"Nature"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1001\/archgenpsychiatry.2012.730","volume":"69","author":"Sullivan P.F.","year":"2012","unstructured":"Sullivan P.F.; Magnusson C.; Reichenberg A.; Family history of schizophrenia and bipolar disorder as risk factors for autism. Arch Gen Psychiatry 2012,69(11),1099-1103","journal-title":"Arch Gen Psychiatry"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1038\/mp.2012.23","volume":"17","author":"Rapoport J.L.","year":"2012","unstructured":"Rapoport J.L.; Giedd J.N.; Gogtay N.; Neurodevelopmental model of schizophrenia: Update 2012. Mol Psychiatry 2012,17(12),1228-1238","journal-title":"Mol Psychiatry"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.cell.2010.03.032","volume":"141","author":"McClellan J.","year":"2010","unstructured":"McClellan J.; King M.C.; Genetic heterogeneity in human disease. Cell 2010,141(2),210-217","journal-title":"Cell"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/mp.2017.77","volume":"23","author":"Duncan L.E.","year":"2018","unstructured":"Duncan L.E.; Ratanatharathorn A.; Aiello A.E.; Largest GWAS of PTSD (N=20\u2009070) yields genetic overlap with schizophrenia and sex differences in heritability. Mol Psychiatry 2018,23(3),666-673","journal-title":"Mol Psychiatry"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nature13595","volume":"511","year":"2014","unstructured":"Schizophrenia working group of the psychiatric genomics consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014,511(7510),421-427","journal-title":"Nature"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/ng1195-321","volume":"11","author":"Moises H.W.","year":"1995","unstructured":"Moises H.W.; Yang L.; Kristbjarnarson H.; An international two-stage genome-wide search for schizophrenia susceptibility genes. Nat Genet 1995,11(3),321-324","journal-title":"Nat Genet"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/nn.3703","volume":"17","author":"Hoischen A.","year":"2014","unstructured":"Hoischen A.; Krumm N.; Eichler E.E.; Prioritization of neurodevelopmental disease genes by discovery of new mutations. Nat Neurosci 2014,17(6),764-772","journal-title":"Nat Neurosci"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.psychres.2014.10.024","volume":"225","author":"Malherbe P.J.","year":"2015","unstructured":"Malherbe P.J.; Roos J.L.; Ehlers R.; Karayiorgou M.; Roos J.L.; Phenotypic features of patients with schizophrenia carrying de novo gene mutations: a pilot study. Psychiatry Res 2015,225(1-2),108-114","journal-title":"Psychiatry Res"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"18209","DOI":"10.1038\/srep18209","volume":"5","author":"Wang Q.","year":"2015","unstructured":"Wang Q.; Li M.; Yang Z.; Increased co-expression of genes harboring the damaging de novo mutations in Chinese schizophrenic patients during prenatal development. Sci Rep 2015,5,18209","journal-title":"Sci Rep"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3371\/CSRP.HUMI.070516","volume":"12","author":"Hudson Z.D.","year":"2018","unstructured":"Hudson Z.D.; Miller B.J.; Meta-Analysis of Cytokine and Chemokine Genes in Schizophrenia. Clin Schizophr Relat Psychoses 2018,12(3),121-129B","journal-title":"Clin Schizophr Relat Psychoses"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1176\/appi.ajp.157.5.683","volume":"157","author":"Kronfol Z.","year":"2000","unstructured":"Kronfol Z.; Remick D.G.; Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry 2000,157(5),683-694","journal-title":"Am J Psychiatry"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41398-018-0366-5","volume":"9","author":"Martinuzzi E.","year":"2019","unstructured":"Martinuzzi E.; Barbosa S.; Daoudlarian D.; Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort study. Transl Psychiatry OPTiMiSE Study Group2019,9(1),20","journal-title":"Transl Psychiatry"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s12031-010-9459-1","volume":"43","author":"Pan W.","year":"2011","unstructured":"Pan W.; Wu X.; Kastin A.J.; Potential protective role of IL15R\u03b1 during inflammation. J Mol Neurosci 2011,43(3),412-423","journal-title":"J Mol Neurosci"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.neubiorev.2012.11.009","volume":"37","author":"Pan W.","year":"2013","unstructured":"Pan W.; Wu X.; He Y.; Brain interleukin-15 in neuroinflammation and behavior. Neurosci Biobehav Rev 2013,37(2),184-192","journal-title":"Neurosci Biobehav Rev"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cytogfr.2016.06.001","volume":"31","author":"Patidar M.","year":"2016","unstructured":"Patidar M.; Yadav N.; Dalai S.K.; Interleukin 15: A key cytokine for immunotherapy. Cytokine Growth Factor Rev 2016,31,49-59","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"5187","DOI":"10.1158\/0008-5472.CAN-15-1498","volume":"75","author":"Pilipow K.","year":"2015","unstructured":"Pilipow K.; Roberto A.; Roederer M.; Waldmann T.A.; Mavilio D.; Lugli E.; IL15 and T-cell Stemness in T-cell-Based Cancer Immunotherapy. Cancer Res 2015,75(24),5187-5193","journal-title":"Cancer Res"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.4049\/jimmunol.156.4.1339","volume":"156","author":"de Jong J.L.","year":"1996","unstructured":"de Jong J.L.; Farner N.L.; Widmer M.B.; Giri J.G.; Sondel P.M.; Interaction of IL-15 with the shared IL-2 receptor beta and gamma c subunits. The IL-15\/beta\/gamma c receptor-ligand complex is less stable than the IL-2\/beta\/gamma c receptor-ligand complex. J Immunol 1996,156(4),1339-1348","journal-title":"J Immunol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1002\/j.1460-2075.1994.tb06576.x","volume":"13","author":"Giri J.G.","year":"1994","unstructured":"Giri J.G.; Ahdieh M.; Eisenman J.; Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J 1994,13(12),2822-2830","journal-title":"EMBO J"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/j.1749-6632.2002.tb04245.x","volume":"966","author":"Kurowska M.","year":"2002","unstructured":"Kurowska M.; Rudnicka W.; Ma\u015bli\u0144ska D.; Ma\u015bli\u0144ski W.; Expression of IL-15 and IL-15 receptor isoforms in select structures of human fetal brain. Ann N Y Acad Sci 2002,966,441-445","journal-title":"Ann N Y Acad Sci"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s12031-009-9319-z","volume":"41","author":"He Y.","year":"2010","unstructured":"He Y.; Wu X.; Khan R.S.; IL-15 receptor deletion results in circadian changes of locomotor and metabolic activity. J Mol Neurosci 2010,41(2),315-321","journal-title":"J Mol Neurosci"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"3120","DOI":"10.1172\/JCI44945","volume":"121","author":"Pistilli E.E.","year":"2011","unstructured":"Pistilli E.E.; Bogdanovich S.; Garton F.; Loss of IL-15 receptor \u03b1 alters the endurance, fatigability, and metabolic characteristics of mouse fast skeletal muscles. J Clin Invest 2011,121(8),3120-3132","journal-title":"J Clin Invest"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.psyneuen.2010.07.017","volume":"36","author":"Wu X.","year":"2011","unstructured":"Wu X.; Hsuchou H.; Kastin A.J.; Interleukin-15 affects serotonin system and exerts antidepressive effects through IL15R\u03b1 receptor. Psychoneuroendocrinology 2011,36(2),266-278","journal-title":"Psychoneuroendocrinology"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.bbi.2010.06.012","volume":"24","author":"Wu X.","year":"2010","unstructured":"Wu X.; He Y.; Hsuchou H.; Kastin A.J.; Rood J.C.; Pan W.; Essential role of interleukin-15 receptor in normal anxiety behavior. Brain Behav Immun 2010,24(8),1340-1346","journal-title":"Brain Behav Immun"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s11011-016-9930-y","volume":"32","author":"Nguyen L.","year":"2017","unstructured":"Nguyen L.; Bohlen J.; Stricker J.; Chahal I.; Zhang H.; Pistilli E.E.; Hippocampus-specific deficiency of IL-15R\u03b1 contributes to greater anxiety-like behaviors in mice. Metab Brain Dis 2017,32(2),297-302","journal-title":"Metab Brain Dis"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"4725","DOI":"10.1523\/JNEUROSCI.6160-09.2010","volume":"30","author":"He Y.","year":"2010","unstructured":"He Y.; Hsuchou H.; Wu X.; Interleukin-15 receptor is essential to facilitate GABA transmission and hippocampal-dependent memory. J Neurosci 2010,30(13),4725-4734","journal-title":"J Neurosci"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"10715","DOI":"10.1074\/jbc.M112.435602","volume":"288","author":"Souza-Fonseca-Guimaraes F.","year":"2013","unstructured":"Souza-Fonseca-Guimaraes F.; Parlato M.; de Oliveira R.B.; Interferon-\u03b3 and granulocyte\/monocyte colony-stimulating factor production by natural killer cells involves different signaling pathways and the adaptor stimulator of interferon genes (STING). J Biol Chem 2013,288(15),10715-10721","journal-title":"J Biol Chem"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"25538","DOI":"10.1074\/jbc.M110.127951","volume":"285","author":"Wilkie S.","year":"2010","unstructured":"Wilkie S.; Burbridge S.E.; Chiapero-Stanke L.; Selective expansion of chimeric antigen receptor-targeted T-cells with potent effector function using interleukin-4. J Biol Chem 2010,285(33),25538-25544","journal-title":"J Biol Chem"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/ni1487","volume":"8","author":"Huntington N.D.","year":"2007","unstructured":"Huntington N.D.; Puthalakath H.; Gunn P.; Interleukin 15-mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1. Nat Immunol 2007,8(8),856-863","journal-title":"Nat Immunol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3109\/08830189809042995","volume":"16","author":"Waldmann T.","year":"1998","unstructured":"Waldmann T.; Tagaya Y.; Bamford R.; Interleukin-2, interleukin-15, and their receptors. Int Rev Immunol 1998,16(3-4),205-226","journal-title":"Int Rev Immunol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/nature08494","volume":"461","author":"Manolio T.A.","year":"2009","unstructured":"Manolio T.A.; Collins F.S.; Cox N.J.; Finding the missing heritability of complex diseases. Nature 2009,461(7265),747-753","journal-title":"Nature"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jneuroim.2010.04.001","volume":"223","author":"Wu X","year":"2010","unstructured":"Wu X; Pan W; He Y; Cerebral interleukin-15 shows upregulation and beneficial effects in experimental autoimmune encephalomyelitis. J Neuroimmunol 36.2010,223,65-72","journal-title":"J Neuroimmunol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.bbr.2010.04.046","volume":"213","author":"Wu X.","year":"2010","unstructured":"Wu X.; Kastin A.J.; Hsuchou H.; Pan W.; The effects of IL2Rgamma knockout on depression and contextual memory. Behav Brain Res 2010,213(2),319-322","journal-title":"Behav Brain Res"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1159\/000315081","volume":"25","author":"Pan W.","year":"2010","unstructured":"Pan W.; Yu C.; Hsuchou H.; Kastin A.J.; The role of cerebral vascular NFkappaB in LPS-induced inflammation: differential regulation of efflux transporter and transporting cytokine receptors. Cell Physiol Biochem 2010,25(6),623-630","journal-title":"Cell Physiol Biochem"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/1043-4666(93)90047-9","volume":"5","author":"Cosman D.","year":"1993","unstructured":"Cosman D.; The hematopoietin receptor superfamily. Cytokine 1993,5(2),95-106","journal-title":"Cytokine"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"3729","DOI":"10.2174\/138161211798220918","volume":"17","author":"Pan W.","year":"2011","unstructured":"Pan W.; Stone K.P.; Hsuchou H.; Manda V.K.; Zhang Y.; Kastin A.J.; Cytokine signaling modulates blood-brain barrier function. Curr Pharm Des 2011,17(33),3729-3740","journal-title":"Curr Pharm Des"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000331720","volume":"28","author":"Stone K.P.","year":"2011","unstructured":"Stone K.P.; Kastin A.J.; Pan W.; NF\u0138B is an unexpected major mediator of interleukin-15 signaling in cerebral endothelia. Cell Physiol Biochem 2011,28(1),115-124","journal-title":"Cell Physiol Biochem"},{"key":"ref=38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0069356","volume":"8","author":"Ouyang S.","year":"2013","unstructured":"Ouyang S.; Hsuchou H.; Kastin A.J.; Pan W.; TNF stimulates nuclear export and secretion of IL-15 by acting on CRM1 and ARF6. PLoS One 2013,8(8)","journal-title":"PLoS One"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.tins.2016.10.009","volume":"39","author":"Volk D.W.","year":"2016","unstructured":"Volk D.W.; Gonzalez-Burgos G.; Lewis D.A.; l-Proline, GABA Synthesis and Gamma Oscillations in Schizophrenia. Trends Neurosci 2016,39(12),797-798","journal-title":"Trends Neurosci"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.schres.2016.10.020","volume":"182","author":"Kim J.H.","year":"2017","unstructured":"Kim J.H.; Kim J.H.; Son Y.D.; Altered interregional correlations between serotonin transporter availability and cerebral glucose metabolism in schizophrenia: A high-resolution PET study using [C]DASB and [F]FDG. Schizophr Res 2017,182,55-65","journal-title":"Schizophr Res"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1084\/jem.191.5.771","volume":"191","author":"Kennedy MK","year":"2000","unstructured":"Kennedy MK; Glaccum M; Brown SN; Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med 33.2000,191,771-80","journal-title":"J Exp Med"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0161-5890(02)00211-0","volume":"39","author":"Lodolce J","year":"2002","unstructured":"Lodolce J; Burkett P; Koka R; Interleukin-15 and the regulation of lymphoid homeostasis. Mol Immunol 342002,39,537-44","journal-title":"Mol Immunol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1111\/j.1471-4159.2009.06371.x","volume":"111","author":"Pan W.","year":"2009","unstructured":"Pan W.; Yu C.; Hsuchou H.; Khan R.S.; Kastin A.J.; Cerebral microvascular IL15 is a novel mediator of TNF action. J Neurochem 2009,111(3),819-827","journal-title":"J Neurochem"},{"key":"ref=44","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jaut.2014.11.003","volume":"56","author":"Hou MS","year":"2015","unstructured":"Hou MS; Huang ST; Tsai MH; The interleukin-15 system suppresses T cell-mediated autoimmunity by regulating negative selection and nT(H)17 cell homeostasis in the thymus. J Autoimmun 35.2015,56,118-29","journal-title":"J Autoimmun"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1176\/appi.ajp.163.3.521","volume":"163","author":"Eaton W.W.","year":"2006","unstructured":"Eaton W.W.; Byrne M.; Ewald H.; Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am J Psychiatry 2006,163(3),521-528","journal-title":"Am J Psychiatry"}],"container-title":["Current Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/172664","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T20:14:51Z","timestamp":1694981691000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/172664\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,5]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,9,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1566524019666190617172054","relation":{},"ISSN":["1566-5240"],"issn-type":[{"type":"print","value":"1566-5240"}],"subject":[],"published":{"date-parts":[[2019,9,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-01-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-25","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}